MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm9123969

Медицинская библиотека · Journal of clinical medicine · 2020

Antihypertensive Treatment in Kidney Transplant Recipients-A Current Single Center Experience.

Jehn Ulrich, Schütte-Nütgen Katharina, Strauss Markus, Kunert Jan, Pavenstädt Hermann, Thölking Gerold, Suwelack Barbara, Reuter Stefan

СтатьяПеревод в очереди

Аннотация

Arterial hypertension affects the survival of the kidney graft and the cardiovascular morbidity and mortality of the recipient after kidney transplantation (KTx). Thus, antihypertensive treatment is necessary for a vast majority of these patients. Long-term data on antihypertensive drugs and their effects on allograft function after KTx is still limited, and further investigation is required. We retrospectively analyzed a cohort of 854 recipients who received a kidney transplant at our transplant center between 2007 and 2015 with regard to antihypertensive treatment and its influence on graft function and survival. 1-y after KTx, 95.3% patients were treated with antihypertensive therapy. Of these, 38.6% received mono- or dual-drug therapy, 38.0% received three to four drugs and 8.1% were on a regimen of ≥5 drugs. Beta-blockers were the most frequently used antihypertensive agents (68.1%). Neither the use of angiotensin-converting enzyme inhibitor/angiotensin receptor blockers (51.9%) and calcium channel blockers (51.5%), nor the use the use of loop diuretics (38.7%) affected allograft survival. Arterial hypertension and the number of antihypertensive agents were associated with unfavorable allograft outcomes (each p < 0.001). In addition to the well-known risk factors of cold ischemic time and acute rejection episodes, the number of antihypertensive drugs after one year, which reflects the severity of hypertension, is a strong predictor of unfavorable allograft survival.

Для цитирования: Jehn Ulrich, Schütte-Nütgen Katharina, Strauss Markus, Kunert Jan, Pavenstädt Hermann, Thölking Gerold, Suwelack Barbara, Reuter Stefan. Antihypertensive Treatment in Kidney Transplant Recipients-A Current Single Center Experience.. Journal of clinical medicine. 2020. DOI: 10.3390/jcm9123969.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.